Enovis (ENOV) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 698.00 |
| Dec 31, 2025 | 1,786.00 |
| Oct 3, 2025 | 1,722.00 |
| Jul 4, 2025 | 2,042.00 |
| Apr 4, 2025 | 1,680.00 |
| Dec 31, 2024 | 1,026.00 |
| Sep 27, 2024 | 1,321.00 |
| Jun 28, 2024 | 1,362.00 |
| Mar 29, 2024 | 1,954.00 |
| Dec 31, 2023 | 2,652.00 |
| Sep 29, 2023 | 2,551.00 |
| Jun 30, 2023 | 2,374.00 |
| Mar 31, 2023 | 2,326.00 |
| Dec 31, 2022 | 2,608.00 |
| Sep 30, 2022 | 2,498.00 |
| Jul 1, 2022 | 2,421.00 |
| Apr 1, 2022 | 2,215.00 |
| Dec 31, 2021 | 2,133.00 |
| Oct 1, 2021 | 2,389.00 |
| Jul 2, 2021 | 2,513.00 |
| Apr 2, 2021 | 2,350.00 |
| Dec 31, 2020 | 1,142.00 |
| Oct 2, 2020 | 1,217.00 |
| Jul 3, 2020 | 687.00 |
| Apr 3, 2020 | 1,034.00 |
| Dec 31, 2019 | 1,208.00 |
| Sep 27, 2019 | 1,144.00 |
| Jun 28, 2019 | 902.00 |
| Mar 29, 2019 | 728.00 |
| Dec 31, 2018 | 108.00 |
| Sep 28, 2018 | 111.00 |
| Jun 29, 2018 | 277.00 |
| Mar 30, 2018 | 392.00 |
| Dec 31, 2017 | 69.00 |
| Sep 29, 2017 | 108.00 |
| Jun 30, 2017 | 32.00 |
| Mar 31, 2017 | 542.00 |
| Dec 31, 2016 | -384.00 |
| Sep 30, 2016 | -451.00 |
| Jul 1, 2016 | -344.00 |
| Apr 1, 2016 | -202.00 |
| Dec 31, 2015 | -434.00 |
| Sep 25, 2015 | -504.00 |
| Jun 26, 2015 | -296.00 |